Sonya Erickson is a member of the firm's board of directors. She has over 30 years of experience counseling emerging growth companies, established technology businesses and venture capital funds. Her clients range from early stage startups to larger public companies.

Download full bio 

Experience

  • Resolution Bio Sells to Agilent 

  • Lattice’s Valuation Climbs to $1 Billion With Series E Round 

  • Rodeo Therapeutics Agrees to Sell to Amgen for $721 Million 

  • Lodo Therapeutics Enters $970 Million Multi-Target Collaboration With Genentech 

  • Alder Biopharmaceuticals $80 Million Initial Public Offering 

  • View all

Education

  • University of Washington School of Law
    JD, 1990

  • Pepperdine University
    BS, Business and Economics
    With honors, 1987


Admissions & Credentials

California

Washington

Memberships

  • Washington State Bar Association

Rankings & Accolades

    Chambers USA: Corporate/Commercial/M&A

    The Best Lawyers in America, Venture Capital Law (2004 - 2019)

    Chambers USA: America's Leading Lawyers for Business (2013 - 2015)

    Washington Super Lawyers (2014 - 2016)